INTRODUCTION
Among workers producing bacterial single-cell protein (BSCP), a temporary endotoxin-associated reduction in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV 1 ), eye inflammation, dermatitis and episodes of fever have been found along with endotoxin in plasma, elevated levels of several acute phase proteins and high levels of neutrophils in sputum. 1e3 BSCP consists of dry bacterial biomass derived mainly from the Gram-negative species Methylococcus capsulatum. The bacteria were cultivated using gas from the North Sea as the carbon source and ammonia as the nitrogen source. The final product, called bioprotein, was used as protein enrichment in animal feed.
Bioprotein has a high endotoxin content originating from the cell walls of the Gram-negative bacteria, which may explain the changes in FVC and FEV 1 and the systemic inflammatory responses observed in these workers.
The plant started production of BSCP based on M.capsulatum in 1998 and was the first such plant in the world. Production was irregular for the first few years but was more consistent from 2004 until the plant closed in 2006.
The aim of the present study was primarily to study lung function effects longitudinally. Possible upper airway effects and blood indicators of inflammation were also investigated. Finally, we wanted to study the effect of exposure termination 1 year after the workers had left the plant.
METHODS Subjects
All 28 workers (including five women) who were working in the plant at the beginning of the study In 2001, preliminary exposure measurements were carried out after the workers complained of fever and eye and airway symptoms. These investigations were followed by blood sample collection performed by the local occupational nurse in 2002 for later analysis. Initially, production was irregular with non-production periods lasting The study was approved by the Regional Ethics Committees for Medical Research in Trondheim and Oslo, Norway. All participants gave their written informed consent at the start and end of the study. The anonymity of the subjects was secured.
Job groups
Downstream operators were process workers handling dry bioprotein during bag filling and spray drier surveillance. Other operators included upstream process workers working with culture fluid, maintenance workers, and development and laboratory engineers. The office workers were located in an office building close to the production plant. The production workers changed their clothes in the office building, and the manager regularly visited the production plant.
Information on jobs performed by the workers during the study period was collected by self-administered questionnaires completed in 2005 and 2007.
Exposure
The exposure of each worker not on leave was measured once during each examination from 2003 to 2005. In 2001, a selection of the workers had been monitored by company staff. Personal samples of inhalable particles were collected for all workers as described previously. 1 Endotoxins were measured by the kinetic LAL method at the company laboratory as described previously, 1 except for four samples collected in 2001 that were analysed at a commercial laboratory. Use of respiratory protection during sampling was recorded by questionnaire.
Pulmonary function tests
Pulmonary function testing was performed using the Spirotrac 2160 spirometer (Vitalograph, Maids Moreton, UK). The same technician (MS) performed all tests according to American Thoracic Society (ATS) criteria. 4 FVC, FEV 1 and forced midexpiratory flow rate (FEF 25e75% ) were measured.
The transfer factor for carbon monoxide (DLco) and the transfer per unit effective alveolar volume (Kco) were measured by the single breath holding method according to the ATS criteria. 5 
Acoustic rhinometry
Nasal cavity dimensions were measured by acoustic rhinometry (Rhin2100; Rhino Metrics, Lynge, Denmark) according to current standards. 6 The repeatability of the measurements has been reported to be less than 5%. 7 In 2004, measurements were performed before and after a work shift. A final test was performed 15 min after decongestion with a spray of xylometazoline. In 2007, the workers were not exposed and measurements were performed before and after decongestion.
Assessment of blood parameters
Leukocytes were analysed in 2003, 2004 and 2005 using Sysmex XE-2100 8 (Fürst Medical Laboratory, Oslo, Norway) within 48 h of blood collection in EDTA vacutainers. In 2007, the cells were analysed using the Sysmex XE-2100 haematology system (Sysmex Europe, Hamburg, Germany) at Oslo University Hospital, Ullevaal, Norway. Serum and plasma were treated and stored according to the criteria of the laboratory.
For the quantitative determination of C-reactive protein (CRP) in human serum, an immunoturbidimetric assay (Tinaquant C-reactive protein (latex) high sensitive assay) on a Hitachi 917 (Roche Diagnostics, Mannheim, Germany) automated clinical chemistry analyser was used. The inter-assay variation (coefficient of variation, CV) was 5%.
The fibrinogen concentrations in citrate plasma samples collected in 2004 were measured at the University Hospital of Trondheim, Norway with a Fibri-Prest Automate using the Clauss clotting method (Medinor ASA, Oslo, Norway). The inter-assay variation (CV) was 4%. In 2007, fibrinogen was analysed in citrate plasma samples using a clotting test on a STA-R Evolution workstation (Diagnostica Stago, Asnières sur Seine, France). The inter-assay variation (CV) was 4%. These blood analyses were performed at Oslo University Hospital, Ullevaal. As two different methods had been used, we calculated the per cent of predicted fibrinogen on the two occasions by taking the highest value of the reported reference range according to the laboratories as 100%.
D-dimer was analysed from plasma samples at the University Hospital of Trondheim, Norway in 2004 using the Tina-quant immunoturbidimetric method on a Hitachi 917. Reported interassay variations for the selected analysis were in the range 6e8% (CV). In 2007, the samples were analysed using an immunoturbidimetric method on the STA-R Evolution workstation. This analysis was performed at Oslo University Hospital, Ullevaal. The inter-assay variation (CV) was 3%. Since two different methods were used, we calculated the per cent of predicted Ddimer on the two occasions by taking the highest value of the reported reference range according to the laboratories as 100%.
The serum samples were analysed for acute phase proteins using a microsphere based multiplexing bioassay system with Xmap technology (Luminex, Austin, Texas, USA). The analyses of interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1 a (MIP-1 a), chemoattractant protein RANTES or CCL5 and platelet-derived growth factor BB (PDGF-BB) were performed according to the instructions of the manufacturer (Bio-Rad, Hercules, California, USA). Eosinophilic cationic protein (ECP), collected both in 2004 and 2007, was analysed in serum samples at Fürst Medical Laboratory, using a fluoroenzyme immunoassay method (UniCAP 1000; Pharmacia, Uppsala, Sweden) with an inter-assay variation (CV) of 4%.
Statistical methods
Standard measures of central tendency and distributions (arithmetic means and SDs) were computed. Exposure data and the outcome variables PDGF-BB, RANTES, ECP, D-dimer and CRP were highly skewed and described by arithmetic means, geometric means (GM), geometric standard deviations (GSD) and range, and were log-transformed before statistical analysis with parametric methods. All tests were two-sided and a significance level of 5% was chosen.
Exposures of job groups were analysed by linear mixed effect models using different groupings and a dichotomous respirator use variable. Models were compared using ML estimation, while the final model was estimated using REML.
Lung function and inflammatory markers in blood were analysed with linear mixed models by a statistician (ØS) as repeated observations were available for each worker. The models take into account the dependency of the repeated observations by adding random effects for workers. In a first analysis, models were constructed using calendar year as predictor (fixed effect). The effect of year is expected to be mainly due to the endotoxin exposure that varied between years when workers changed job types and after closure of the plant. In a second analysis, we divided the workers into categories with low versus high endotoxin exposure, and then analysed the effect of calendar year for these two categories. As only a few endotoxin measurements had been performed before 2003, we excluded CRP, RANTES, IL-6, MIP-1a, PDGF-BB and MCP-1 from this second analysis. In both analyses, we chose 2007 (1 year after exposure ceased) as the baseline because endotoxin exposure then was assumed to be low. The associations were adjusted for gender, age, height, weight, smoking status and asthma. The two models can be represented formally by
Here, y ij is the observed lung function, or inflammatory parameter, of worker i and replication j, x T ij is a vector of regressors linking the observations to the fixed effects b.
Furthermore, u i are independent and identically normal distributed random effects with mean 0 and variance s 2 u , while 3 ij are AM, arithmetic mean; GM, geometric mean; GSD, geometric SD; n, number of measurements; e, no data. Figure 1 Total leukocyte cell counts, and levels of C reactive protein (CRP), eosinophilic cationic protein (ECP), interleukin-6 (IL-6), platelet-derived growth factor BB (PDGF-BB), chemoattractant protein RANTES, monocyte chemoattractant protein-1(MCP-1) and macrophage inflammatory protein-1 a (MIP-1a) in blood from workers in a bacterial single-cell protein (BSCP) factory (n¼28). The horizontal line represents the mean. *p<0.05, **p#0.01, ***p<0.001.
identically independent distributed normal random variables with mean 0 and variance s 2 3 . Nasal dimensions were compared by paired t tests and associations between changes in dimensions and exposure were adjusted for gender and smoking by multiple regression.
Analysis by linear mixed models was performed with the nlme package in R (http://www.r-project.org) and all other tests were performed with SPSS v 16.0 for Windows (SPSS, Chicago, Illinois, USA).
RESULTS Exposure
The endotoxin levels during regular work from 2001 to 2005 are shown in table 2. Measurements with and without the use of respiratory protection are shown separately (table 2). Different groupings were attempted but due to Hessian matrices not being positive definite, only models with downstream operators and a group including all other job types could be modelled. These models showed that neither year nor respirator use were significantly associated with endotoxin exposure, and the model with only two job groups had the lowest Akaike's information criterion. The final model estimated the GM endotoxin exposure level of the downstream workers at 6700 EU/m 3 and of the other workers at 230 EU/m 3 . Using the residual variance from the model, the arithmetic mean exposure levels were estimated to be 11 000 and 390 EU/m 3 , respectively. 9 Inclusion of the dichotomous job type variable in the model reduced the between-worker variance from 3.32 to 0.40 (À88%) and the within-worker variance from 1.11 to 1.03 (À7%). is FEV 1 in 2007, we found that the total group had a mean annual increase in FEV 1 of 8 ml/year (SD 69). Accordingly, the low exposure group had a mean increase of 37 ml/year (SD 76), whereas the high exposure group had a mean loss of 14 ml/year (SD 56) with no significant difference between the groups (p¼0.07).
Health effects
No significant differences for the two exposure groups were found for D L co or Kco between the 2004 and 2007 levels (table 4) .
In 2007, the anterior volume of the nose had increased significantly by 0.44 cm 3 (SE 0.10, p<0.001) and the anterior cross-section was significantly greater by 0.18 cm 2 (SE 0.058, p¼0.005). No associations were found between the change in nasal dimensions from 2004 to 2007 and exposure to endotoxins.
Blood parameters
The observed blood parameters of all workers are shown in figure 1 where significant calendar year differences are indicated. Table 3 Descriptive lung function data in 28 workers in a bacterial single-cell protein factory during follow-up 
DISCUSSION
We have found endotoxin exposure levels often exceeding 10 000 EU/m 3 among former workers at a BSCP plant where coexposure to other components that correlate with endotoxin exposure is lacking. The changes in FVC and FEV 1 were significantly associated with previous exposure to endotoxin but only among the lower exposed group, with an arithmetic mean endotoxin exposure of 390 EU/m
3 . An increase in the dimensions of the anterior section of the nose and normalisation of peripheral blood leukocytosis and levels of acute phase proteins were found. There were significant associations of endotoxin exposure with number of leukocytes among the high exposure group with an arithmetic mean exposure of 5800e11 000 EU/m 3 and levels of ECP and D-dimer for both the high and low exposure group. Selected acute phase proteins were temporally reduced during sustained high levels of endotoxin exposure.
The lung is considered the main target organ for airborne endotoxin exposure. Termination of exposure to endotoxins was associated with significant increases in FVC and FEV 1 , but only in the lower exposure group, possibly reflecting sustained lung inflammation among workers with the highest exposure levels. An accelerated loss in lung function with an excess decline of 9 ml/year was also found among grain farmers, which is in the same magnitude as the total loss of 14 ml/year among the high exposure group in this study. 10 However, the decline in lung function among endotoxin exposed workers has been shown to normalise once exposure ceases. 11 12 Among cotton workers, cessation resulted in a 7% increase in mean per cent of predicted FEV 1 , which is in agreement with the results in the present low exposure group. 11 We did not observe changes in diffusing capacity, which may be because the BSCP consisted of large aggregates affecting the eyes and not reaching the alveoli (Wijnand Eduard, unpublished results). 1 In 2007, the dimensions of the anterior part of the nose were increased compared to 2004. However, this may not indicate the reversal of mucosal swelling as no changes were observed in the interior part of the nose where the mucosal area is substantially larger.
Inhalation of endotoxins may induce a systemic inflammatory response by activation of macrophages and influx of neutrophils into the lung. 3 In the present study, we found an increase of IL-6 in 2002, and the endotoxin-associated increase in blood leukocytes, ECP and fibrin D-dimer was reversed 1 year after the plant closed. Endotoxin was shown to be present in the blood of the workers, and thus direct stimulation of circulatory immune cells seems possible. 2 Consequently, both mechanisms can result in an increase in acute phase proteins.
Tolerance, known to result in both impaired and augmented activities when cells are restimulated with lipopolysaccharide, 
